Managing nocardiosis: a review and case series of its treatment with trimethoprim –sulfamethoxazole

We report a case series of nocardiosis with diverse clinical presentations (primary pulmonary, primary cutaneous, and disseminated) and successful treatment with trimethoprim –sulfamethoxazole (TMP–SMX). We briefly review the cases to assess the efficacy of treatment with TMP–SMX. The optimal therapy for nocardiosis has yet to be established. Our clinical experience, together with the clinical evidence in the literature, suggests that TMP–SMX should be considered as the therapeutic drug of choice for treating nocardiosis.
Source: Drugs and Therapy Perspectives - Category: Drugs & Pharmacology Source Type: research